Obseva Logo highresolution.jpg
ObsEva Announces Appointment of Luigi Marro as Chief Transformation Officer
September 30, 2021 01:00 ET | ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange   GENEVA, Switzerland – September 30, 2021 – ObsEva SA (NASDAQ: OBSV) (SIX: OBSN), a biopharmaceutical company developing and...
Axtria Honored on NJ
Axtria Honored on NJBIZ’s “Top 250 Privately Held Companies” For The Fourth Time
September 30, 2020 12:51 ET | Axtria Inc.
Berkeley Heights, NJ, Sept. 30, 2020 (GLOBE NEWSWIRE) -- Axtria, a global leader in software technology and data analytics for the life sciences industry, is delighted to announce its ranking...
Marina-Biotech-Inc_Logo.jpg
Marina Biotech Appoints Jay D. Schwartz to serve as Senior Vice President, Commercial Operations
August 06, 2018 09:15 ET | Marina Biotech, Inc.
City of Industry, CA, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of...